Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Casanova MJ, Nantes Ó, Varela P, Vela-González M, Rivero M, Sierra-Gabarda O, Riestra S, Barreiro-de Acosta M, Martín-Rodríguez MDM, Gargallo-Puyuelo CJ, Reygosa C, Muñoz R, de la Filia-Molina IG, Núñez-Ortiz A, Kolle L, Calafat M, Huguet JM, Iglesias-Flores E, Martínez-Pérez TJ, Bosch O, Duque-Alcorta JM, Frago-Larramona S, Van Domselaar M, González-Cosano VM, Bujanda L, Rubio S, Mancebo A, Castro B, García-López S, de Francisco R, Nieto-García L, Laredo V, Gutiérrez-Casbas A, Mesonero F, Leo-Carnerero E, Cañete F, Ruiz L, Gros B, Del Moral-Martínez M, Rodríguez C, Chaparro M, Gisbert JP. Casanova MJ, et al. Among authors: reygosa c. Aliment Pharmacol Ther. 2023 Jul;58(1):60-70. doi: 10.1111/apt.17525. Epub 2023 Apr 23. Aliment Pharmacol Ther. 2023. PMID: 37089065
COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
Ramos L, Carrillo-Palau M, Alonso-Abreu I, Reygosa C, Hernández-Alvarez N, Amaral C, Hernández A, Benítez-Zafra F, Pérez-González F, Quintana-Díaz H, Hernandez-Guerra M. Ramos L, et al. Among authors: reygosa c. Gastroenterol Hepatol. 2023 Apr;46(4):255-260. doi: 10.1016/j.gastrohep.2022.05.009. Epub 2022 May 21. Gastroenterol Hepatol. 2023. PMID: 35609791 Free PMC article.
Increasing the low residue diet to 3 days does not improve the bowel cleansing in hard to prepare patients: Post hoc analysis of a randomized controlled trial.
Gimeno-García AZ, de la Barreda-Heuser R, Reygosa C, Hernández A, Amaral C, Mascareño I, Nicolás-Pérez D, Jiménez A, Lara AJ, Hernández A, Felipe V, Baute JL, Alarcon-Fernández O, Hernandez-Guerra M, Romero R, Alonso I, González Y, Adrian Z, Hernandez G, Hernandez D, Delgado R, Quintero E. Gimeno-García AZ, et al. Among authors: reygosa c. Gastroenterol Hepatol. 2021 Mar;44(3):183-190. doi: 10.1016/j.gastrohep.2020.06.016. Epub 2020 Sep 15. Gastroenterol Hepatol. 2021. PMID: 32948359 Clinical Trial. English, Spanish.
Usefulness of a novel computer-aided detection system for colorectal neoplasia: a randomized controlled trial.
Gimeno-García AZ, Hernández Negrin D, Hernández A, Nicolás-Pérez D, Rodríguez E, Montesdeoca C, Alarcon O, Romero R, Baute Dorta JL, Cedrés Y, Castillo RD, Jiménez A, Felipe V, Morales D, Ortega J, Reygosa C, Quintero E, Hernández-Guerra M. Gimeno-García AZ, et al. Among authors: reygosa c. Gastrointest Endosc. 2023 Mar;97(3):528-536.e1. doi: 10.1016/j.gie.2022.09.029. Epub 2022 Oct 11. Gastrointest Endosc. 2023. PMID: 36228695 Clinical Trial.
Impact of a 1-day versus 3-day low-residue diet on bowel cleansing quality before colonoscopy: a randomized controlled trial.
Gimeno-García AZ, de la Barreda Heuser R, Reygosa C, Hernandez A, Mascareño I, Nicolás-Pérez D, Jiménez A, Lara AJ, Alarcon-Fernández O, Hernandez-Guerra M, Romero R, Alonso I, González Y, Adrian Z, Hernandez G, Hernandez D, Delgado R, Quintero E. Gimeno-García AZ, et al. Among authors: reygosa c. Endoscopy. 2019 Jul;51(7):628-636. doi: 10.1055/a-0864-1942. Epub 2019 Apr 3. Endoscopy. 2019. PMID: 30943553 Clinical Trial.
An Enhanced High-Volume Preparation for Colonoscopy Is Not Better Than a Conventional Low-Volume One in Patients at Risk of Poor Bowel Cleansing: A Randomized Controlled Trial.
Gimeno-García AZ, Hernández G, Baute Dorta JL, Reygosa C, de la Barreda R, Hernandez-Bustabad A, Amaral C, Cedrés Y, Del Castillo R, Nicolás-Pérez D, Jiménez A, Alarcon-Fernández O, Hernandez-Guerra M, Romero R, Alonso I, González Y, Adrian Z, Hernandez D, Ramos L, Carrillo M, Felipe V, Hernández A, Rodríguez-Jiménez C, Quintero E. Gimeno-García AZ, et al. Among authors: reygosa c. Front Med (Lausanne). 2021 Mar 22;8:654847. doi: 10.3389/fmed.2021.654847. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33829030 Free PMC article.
Usefulness of prioritization systems during the resumption of gastrointestinal endoscopy activity during the COVID-19 pandemic.
Gimeno-García AZ, Hernández A, Hernández-Bustabad A, Amaral C, Reygosa C, Morales-Arraez D, Jimenez A, Nicolás-Pérez D, Hernández-Guerra M. Gimeno-García AZ, et al. Among authors: reygosa c. Endoscopy. 2021 Jun;53(6):662-663. doi: 10.1055/a-1453-0206. Epub 2021 Apr 26. Endoscopy. 2021. PMID: 33902113 No abstract available.
Polypoid endometriosis simulating an advanced ovarian neoplasm with infiltration of the intestinal wall: Echoendoscopic description of the case.
Amaral C, González L, Reygosa C, Hernández A, Hernández A, Hernández-Guerra M, Amaya F, Gimeno-García AZ. Amaral C, et al. Among authors: reygosa c. Gastroenterol Hepatol. 2021 Jun-Jul;44(6):433-434. doi: 10.1016/j.gastrohep.2020.06.026. Epub 2020 Oct 6. Gastroenterol Hepatol. 2021. PMID: 33036800 English, Spanish. No abstract available.
13 results